Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Eur Rev Med Pharmacol Sci ; 28(4): 1562-1574, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38436189

ABSTRACT

OBJECTIVE: The objective of this study was to assess treatment outcomes of intensity-modulated radiotherapy with concomitant chemotherapy and to identify prognostic factors on survival in patients with limited-stage small-cell lung cancer. PATIENTS AND METHODS: A retrospective analysis was conducted on a cohort of seventy-two patients who received curative treatment between December 2011 and January 2023. Several clinical and biochemical parameters were examined as potential prognostic factors. RESULTS: The median age was 63 years, and 79% of them were males. Concomitant chemotherapy was administered in 83% of patients. Prophylactic cranial irradiation was applied in 61% of the cohort. Two and five-year overall survival (OS), disease-free survival (DFS), and local relapse-free survival (LRFS) rates were 50% and 25%, 38% and 24%, and 44% and 25%, respectively. Univariate analysis revealed that older age, comorbid lung disease, advanced tumor-node-metastasis (TNM) stage, radiotherapy (RT) alone, and the absence of prophylactic cranial irradiation (PCI) were adverse factors affecting OS. The advanced TNM stage emerged as a significant prognostic factor for LRFS and DFS, with a notable trend toward affecting OS. CONCLUSIONS: The TNM staging system is of significance in cases classified as limited-stage small-cell lung cancer due to its prognostic implications. Our results suggest that patients with more advanced TNM stage exhibit less favorable treatment outcomes, which may require individual tailoring of new systemic therapies.


Subject(s)
Lung Neoplasms , Radiotherapy, Intensity-Modulated , Small Cell Lung Carcinoma , Male , Humans , Middle Aged , Female , Lung Neoplasms/radiotherapy , Retrospective Studies , Small Cell Lung Carcinoma/radiotherapy , Disease-Free Survival
2.
Med Sci Monit ; 23: 3178-3184, 2017 Jun 29.
Article in English | MEDLINE | ID: mdl-28662014

ABSTRACT

BACKGROUND Immunization is one of the most effective public health measures to prevent disease, but vaccination rates in adult populations still remain below the targets. Patient and physician attitudes about vaccination are important for adult vaccination. In this study, we aimed to determine patient attitudes and perceptions about vaccination and the vaccination coverage rates of adult patients in a university hospital in Turkey. MATERIAL AND METHODS A survey was conducted between October 2014 and May 2015 at the Internal Medicine Outpatient Clinics of a university hospital. Adult patients were asked to fill out a questionnaire on their perceptions and attitudes about vaccination and their vaccination status. RESULTS We interviewed 512 patients ages 19-64 years. Eighty percent of the study population thought that adults should be vaccinated, while only 36.1% of the patients stated that vaccination was ever recommended to them in their adult life. Forty-eight percent of the patients stated that they were vaccinated at least once in their adulthood. The most commonly received vaccine was tetanus vaccine in general, while influenza vaccine was the leading vaccine among patients with chronic medical conditions. While 71.4% of the patients to whom vaccination was recommended received the vaccine, 34.9% of the patients received a vaccine without any recommendation. CONCLUSIONS Although the vaccine coverage rates among adults in this survey were low, the perceptions of patients about adult vaccination were mainly positive and of many of them positively reacted when their physician recommended a vaccine.


Subject(s)
Health Knowledge, Attitudes, Practice , Perception , Vaccination , Adult , Comorbidity , Demography , Female , Health Personnel , Humans , Male , Middle Aged , Vaccines/immunology , Young Adult
3.
Hum Vaccin Immunother ; 11(12): 2806-10, 2015.
Article in English | MEDLINE | ID: mdl-26366628

ABSTRACT

Many infectious diseases in adults can be prevented by a 'life-long vaccination strategy'. Hepatitis B disease burden was shown to be higher in diabetic patients. American Advisory Committee on Immunization Practices recommends to vaccinate diabetic patients against hepatitis B since 2011. In this study, we aimed to determine hepatitis B virus serology status to determine the rates of diabetic patients who have indications for hepatitis B vaccination. The electronic database of the hospital was searched to identify adult patients aged above 18 years and with hemoglobin A1C levels of 6.5% or above, who have been seen at General Medicine Outpatient Clinics of a university hospital during a 3-year period. A total of 5187 patients were included in the study. After exclusion of patients with an incomplete serological panel, 1358 patients were included for further analyses. Twenty-nine percent of the patients had indication for hepatitis B vaccination, whereas only 8% were vaccinated. This study showed that nearly one third of patients who had hepatitis B serological data had an indication for hepatitis B vaccination and this is a clear reflection of the need to keep a lifelong vaccination log and inquire vaccination data.


Subject(s)
Diabetes Mellitus , Hepatitis B Vaccines/therapeutic use , Hepatitis B/epidemiology , Hepatitis B/prevention & control , Adult , Diabetes Complications/virology , Female , Hepatitis B Antibodies/blood , Hepatitis B Antibodies/immunology , Hepatitis B Core Antigens/blood , Hepatitis B Core Antigens/immunology , Hepatitis B Surface Antigens/blood , Hepatitis B Surface Antigens/immunology , Hepatitis B Vaccines/immunology , Humans , Male , Middle Aged , Seroepidemiologic Studies , Vaccination , Young Adult
5.
Mol Psychiatry ; 19(10): 1115-24, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25178163

ABSTRACT

The NAP motif of activity-dependent neuroprotective protein (ADNP) enhanced memory scores in patients suffering from mild cognitive impairment and protected activities of daily living in schizophrenia patients, while fortifying microtubule (MT)-dependent axonal transport, in mice and flies. The question is how does NAP fortify MTs? Our sequence analysis identified the MT end-binding protein (EB1)-interacting motif SxIP (SIP, Ser-Ile-Pro) in ADNP/NAP and showed specific SxIP binding sites in all members of the EB protein family (EB1-3). Others found that EB1 enhancement of neurite outgrowth is attenuated by EB2, while EB3 interacts with postsynaptic density protein 95 (PSD-95) to modulate dendritic plasticity. Here, NAP increased PSD-95 expression in dendritic spines, which was inhibited by EB3 silencing. EB1 or EB3, but not EB2 silencing inhibited NAP-mediated cell protection, which reflected NAP binding specificity. NAPVSKIPQ (SxIP=SKIP), but not NAPVAAAAQ mimicked NAP activity. ADNP, essential for neuronal differentiation and brain formation in mouse, a member of the SWI/SNF chromatin remodeling complex and a major protein mutated in autism and deregulated in schizophrenia in men, showed similar EB interactions, which were enhanced by NAP treatment. The newly identified shared MT target of NAP/ADNP is directly implicated in synaptic plasticity, explaining the breadth and efficiency of neuroprotective/neurotrophic capacities.


Subject(s)
Dendritic Spines/physiology , Homeodomain Proteins/metabolism , Microtubules/metabolism , Nerve Tissue Proteins/metabolism , Animals , COS Cells , Cells, Cultured , Chlorocebus aethiops , Disks Large Homolog 4 Protein , Escherichia coli , Guanylate Kinases/metabolism , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Nerve Tissue Proteins/genetics , Neurons/physiology , PC12 Cells , Protein Interaction Domains and Motifs , Rats , Recombinant Proteins/metabolism , Tubulin/metabolism
6.
Rheumatol Int ; 34(11): 1563-9, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24715239

ABSTRACT

Most patients with osteoporosis are postmenopausal women or senile people who are deemed to have primary osteoporosis. However, young women, males, and atypical cases need further work up to evaluate the risk factors for secondary osteoporosis. A growing body of literature has accumulated regarding the role of osteoporosis in the onset and progression of periodontal disease and tooth loss. We hypothesized that secondary/idiopathic osteoporosis in young patients will be associated with worse periodontal status. Patients and controls who were seen in the general internal medicine outpatient clinic and who were less than 47 years of age were recruited between December 2005 and June 2011. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Blood samples were obtained for bone turnover markers and secondary causes of low BMD. Periodontal variables were assessed. Forty-five women whose mean age was 33.9 ± 7.7 years were enrolled. The osteoporotic group consisted of 12 patients, the osteopenic group 17 patients, and the control group 16 subjects. Significantly higher gingival recession (GR), gingival bleeding time index, and hence gingival inflammation were noted in patients with secondary osteoporosis compared to healthy subjects. In logistic regression analysis, having osteoporosis was determined as the single risk factor for increased bleeding time (b = 0.871, p = 0.008), while having osteoporosis (b = 0.181, p = 0.001) and age (b = 0.010, p < 0.001) were significant parameters with regard to GR. In conclusion, low BMD in young individuals was associated with greater gingival inflammation and recession when compared to those individuals with normal BMD values.


Subject(s)
Bone Density , Bone Diseases, Metabolic/complications , Gingival Recession/etiology , Gingivitis/etiology , Osteoporosis/complications , Absorptiometry, Photon , Adolescent , Adult , Age Factors , Bone Diseases, Metabolic/diagnosis , Bone Diseases, Metabolic/physiopathology , Case-Control Studies , Chi-Square Distribution , Female , Gingival Recession/diagnosis , Gingival Recession/physiopathology , Gingivitis/diagnosis , Gingivitis/physiopathology , Humans , Linear Models , Logistic Models , Middle Aged , Osteoporosis/diagnosis , Osteoporosis/physiopathology , Predictive Value of Tests , Risk Factors , Young Adult
7.
Leukemia ; 27(9): 1841-51, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23797473

ABSTRACT

Ineffective hematopoiesis is a major characteristic of myelodysplastic syndromes (MDS) causing relevant morbidity and mortality. Mesenchymal stromal cells (MSC) have been shown to physiologically support hematopoiesis, but their contribution to the pathogenesis of MDS remains elusive. We show that MSC from patients across all MDS subtypes (n=106) exhibit significantly reduced growth and proliferative capacities accompanied by premature replicative senescence. Osteogenic differentiation was significantly reduced in MDS-derived MSC, indicated by cytochemical stainings and reduced expressions of Osterix and Osteocalcin. This was associated with specific methylation patterns that clearly separated MDS-MSC from healthy controls and showed a strong enrichment for biological processes associated with cellular phenotypes and transcriptional regulation. Furthermore, in MDS-MSC, we detected altered expression of key molecules involved in the interaction with hematopoietic stem and progenitor cells (HSPC), in particular Osteopontin, Jagged1, Kit-ligand and Angiopoietin as well as several chemokines. Functionally, this translated into a significantly diminished ability of MDS-derived MSC to support CD34+ HSPC in long-term culture-initiating cell assays associated with a reduced cell cycle activity. Taken together, our comprehensive analysis shows that MSC from all MDS subtypes are structurally, epigenetically and functionally altered, which leads to impaired stromal support and seems to contribute to deficient hematopoiesis in MDS.


Subject(s)
Mesenchymal Stem Cells/metabolism , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/metabolism , Adult , Aged , Aged, 80 and over , Case-Control Studies , Cell Differentiation , Cell Proliferation , Cellular Senescence , Cluster Analysis , Colony-Forming Units Assay , DNA Methylation , Epigenesis, Genetic , Female , Gene Expression Profiling , Humans , Immunophenotyping , Male , Mesenchymal Stem Cells/cytology , Middle Aged , Osteogenesis/genetics , Phenotype
8.
Clin Rheumatol ; 29(11): 1285-93, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20697762

ABSTRACT

The aim of this study is to evaluate the effects of estrogen receptor 1 (ESR1) and vitamin D receptor (VDR) gene polymorphisms on bone mineral density (BMD) in a group of previously untreated osteoporotic women. Effects of demographic, environmental, and hormonal factors were also evaluated in this context. Fifty women who did not have a prior diagnosis or treatment of osteoporosis were compared with 50 nonosteoporotic postmenopausal women. Demographic and morphometric characteristics, medical history, dietary habits, exercise history, and sunlight exposure were recorded. The diagnosis of osteoporosis was made with regard to BMD measurements with DEXA. Blood samples were obtained for serum biochemistry, bone turnover markers, and VDR and ESR1 gene polymorphism analysis. Polymorphic sites of VDR and ESR1 genes were amplified by polymerase chain reaction and examined using restriction fragment length polymorphism. Bb genotype was significantly higher in the osteoporotic group when compared to controls (p=0.022). Each 1 U decrease in the body mass index (BMI) increased the risk of osteoporosis by 8% independent of the genotype. We could not observe a significant effect of ESR1 polymorphism on BMD or osteoporosis risk. The interaction of ApaI and BsmI genotypes were found to be significant (p=0.041) and the AaBb genotype, when corrected for BMI, was shown to increase the risk of osteoporosis five times (p=0.005). However, the results demonstrated insignificant p values when correction for multiple testing was performed with the Bonferroni method in the logistic regression model. A predominance of Bb genotype of the VDR gene was evident in this group of postmenopausal Turkish women. Moreover, the combined genotype AaBb conferred a five times increased risk for osteoporosis when corrected for clinical variables.


Subject(s)
Estrogen Receptor alpha/genetics , Genetic Predisposition to Disease , Osteoporosis, Postmenopausal/genetics , Polymorphism, Genetic , Receptors, Calcitriol/genetics , Aged , Alleles , Body Mass Index , Bone Density , Female , Genotype , Humans , Middle Aged , Osteoporosis, Postmenopausal/diagnosis , Postmenopause , Risk
9.
Oral Dis ; 16(7): 648-54, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20412449

ABSTRACT

OBJECTIVE: This study was conducted to assess the effect of improved periodontal health following periodontal treatment on metabolic lipid control of patients on anti-lipemic treatment. MATERIALS AND METHODS: The study population consisted of 20 patients aged 34-62 years with diagnoses of hyperlipidemia and chronic periodontitis. All patients used statin to treat their elevated levels of low-density lipoprotein cholesterol. Blood samples were obtained for measurement of serum lipids, fasting plasma glucose, and high sensitive C-reactive protein. Periodontal parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and percentage of bleeding on probing, were evaluated. All parameters were assessed in each subject at baseline, after 3 months as a control (at the time of periodontal treatment), and 3 months after the non-surgical periodontal treatment that included scaling and root planning. RESULTS: All lipid parameters decreased after the periodontal treatment, but only the decreases in total cholesterol and low-density lipoprotein cholesterol levels reached statistical significance compared to baseline (P = 0.002 and P = 0.003, respectively). CONCLUSION: Improved periodontal health may influence metabolic control of hyperlipidemia and could be considered as an adjunct to the standard measures of hyperlipidemic patient care.


Subject(s)
Chronic Periodontitis/therapy , Hyperlipidemias/drug therapy , Adult , Anticholesteremic Agents/therapeutic use , Atorvastatin , Blood Glucose/analysis , Body Mass Index , C-Reactive Protein/analysis , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Dental Plaque Index , Dental Scaling , Female , Follow-Up Studies , Gingival Hemorrhage/therapy , Heptanoic Acids/therapeutic use , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hyperlipidemias/blood , Male , Middle Aged , Oral Hygiene , Periodontal Attachment Loss/therapy , Periodontal Index , Periodontal Pocket/therapy , Pyrroles/therapeutic use , Root Planing , Treatment Outcome , Triglycerides/blood
10.
Arch Gerontol Geriatr ; 50(3): e13-8, 2010.
Article in English | MEDLINE | ID: mdl-19481270

ABSTRACT

Hip fractures are a burden to both society and the individual. The aim of this study was to describe the frequency of osteoporosis and the in-hospital treatment costs of patients with hip fractures admitted to Hacettepe University Faculty of Medicine Hospital. Patients with a hip fracture who were admitted to the Orthopedics and Traumatology wards between April 2003 and December 2006 were interviewed and 50 of them were enrolled prospectively in the study protocol. Patient characteristics, predisposing factors for fractures and hospital costs were recorded as well as laboratory test results and bone mineral density measurements. The mean age was 74.2 years and 72% of the patients were women. Sixty-four percent of them presented with an intertrochanteric fracture. The patient population was significantly debilitated with a high prevalence of vitamin D insufficiency and secondary hyperparathyroidism. No association was shown with T scores and dietary habits and lifestyle characteristics of patients. In 34% of patients in whom measurements were available, no osteoporosis could be documented. The mean hospital expenditure was $5983. Factors affecting the total cost were age and functional status of the patient and the duration of hospital stay, independent of the type of fracture and surgical procedure used.


Subject(s)
Fractures, Spontaneous/epidemiology , Hip Fractures/epidemiology , Osteoporosis/epidemiology , Aged , Causality , Female , Fractures, Spontaneous/economics , Fractures, Spontaneous/etiology , Fractures, Spontaneous/prevention & control , Health Care Costs , Hip Fractures/economics , Hip Fractures/etiology , Hip Fractures/prevention & control , Humans , Male , Osteoporosis/economics , Osteoporosis/etiology , Osteoporosis/prevention & control , Prospective Studies , Turkey/epidemiology , Vitamin D Deficiency/epidemiology
11.
Spine J ; 9(4): e20-4, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18790681

ABSTRACT

BACKGROUND CONTEXT: Pregnancy- and lactation-associated osteoporosis is an uncommon condition that may be a consequence of preexisting low bone density, loss of bone mineral content during pregnancy, and increased bone turnover. PURPOSE: To present a case of severe osteoporosis associated with pregnancy and lactation and its treatment protocol. STUDY DESIGN/SETTING: A tertiary care hospital. PATIENT SAMPLE: A young female after twin pregnancy presenting with severe osteoporosis. METHODS: The diagnosis was done on the basis of bone mineral density (BMD) measurement. The patient was treated with first alendronate and then strontium ranelate. She was considered as a candidate for kyphoplasty. RESULTS: A dramatic increase in the BMD and palliation of back pain were observed. CONCLUSIONS: Strontium ranelate may be a new alternative in the treatment of pregnancy- and lactation-associated osteoporosis.


Subject(s)
Bone Density Conservation Agents/administration & dosage , Lactation , Organometallic Compounds/administration & dosage , Osteoporosis/drug therapy , Osteoporosis/etiology , Pregnancy Complications , Thiophenes/administration & dosage , Back Pain/diagnostic imaging , Back Pain/etiology , Back Pain/pathology , Bone Density/drug effects , Female , Femur/diagnostic imaging , Femur/pathology , Humans , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/pathology , Osteoporosis/pathology , Polycystic Ovary Syndrome/complications , Postpartum Period , Pregnancy , Radiography , Severity of Illness Index , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/pathology , Young Adult
12.
South Med J ; 100(7): 686-91, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17639748

ABSTRACT

BACKGROUND: The authors aimed to evaluate whether local periodontal therapy may influence plasma lipid levels in patients with periodontitis. METHODS: Fifty patients (31 females and 19 males, age 36-66 yr) were randomly assigned to the treatment and control groups. Lipid profile and dental variables were measured at baseline and at the end of the study in both groups. RESULTS: In the third month, there was a significant decrease in total and low density lipoprotein (LDL) cholesterol levels of the treatment group compared with baseline values. Also, the reduction in bleeding on probing, pocket depth, attachment loss, plaque index and gingival index were statistically significant in the treatment group. CONCLUSIONS: The present study indicates that periodontitis causes changes in total and LDL cholesterol levels and local periodontal treatment resulted in a significant decrease in these markers. These results suggest a potential effect of periodontitis-driven systemic inflammation on lipid metabolism.


Subject(s)
Cholesterol/blood , Hypercholesterolemia/therapy , Periodontitis/blood , Periodontitis/therapy , Triglycerides/blood , Adult , Cardiovascular Diseases/blood , Cardiovascular Diseases/prevention & control , Female , Humans , Hypercholesterolemia/complications , Male , Middle Aged , Periodontitis/complications , Root Planing
13.
J Natl Med Assoc ; 98(10): 1598-604, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17052049

ABSTRACT

The objectives of this study were to determine whether type-2 diabetes was associated with a higher bone mineral density (BMD) in men and women and to evaluate the differences in mineral metabolism between diabetic and normal subjects by using biochemical bone turnover markers. In this study, 52 patients (37 females/15 males) aged 41-64 with type-2 diabetes mellitus and 48 nondiabetic control subjects (34 females/14 males) were evaluated. In men, BMD was significantly higher in diabetics at the forearm (p <0.05), whereas in women tended to be higher at the hip (p=0.002). Serum osteocalcin (p<0.0001), bone alkaline phosphatase (BAP) (p<0.05) and carboxyterminal telopeptide (CTx) (p<0.05) were higher in the control group than in diabetics. In men, serum osteocalcin (p<0.05) and CTx (p<0.005) and, in women, serum osteocalcin (p<0.0001) and BAP (p<0.05) were lower in diabetic subjects. In conclusion, our findings suggest that although bone formation is decreased in type-2 diabetes, diabetic patients are not susceptible to bone resorption. This low bone turnover can slow the rate of bone loss and cause a higher bone density than expected for their age.


Subject(s)
Bone Density/physiology , Bone and Bones/metabolism , Diabetes Mellitus, Type 2/metabolism , Adult , Alkaline Phosphatase/metabolism , Biomarkers/metabolism , Bone Resorption/etiology , Bone Resorption/metabolism , Collagen Type I/metabolism , Diabetes Mellitus, Type 2/complications , Female , Humans , Male , Middle Aged , Osteocalcin/blood , Peptides/metabolism , Prognosis
14.
Clin Appl Thromb Hemost ; 12(3): 364-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16959692

ABSTRACT

Obesity and its associated metabolic complications can impair the physiologic regulation of fibrinolysis, leading to a hyper coagulable state. We aimed to assess circulating thrombin activatable fibrinolysis inhibitor (TAFI) levels in obese female patients and to test the effects of orlistat-induced weight loss on basal TAFI concentrations. Obese female outpatients age 18 and older, with a body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of at least 30, were included into the study. Thirteen nonobese (median BMI, 22.60 kg/m(2)) age-matched females were taken as controls. Plasma TAFI levels were measured before orlistat administration and after 6 months of orlistat treatment in the obese group and only one measurement was done in the control group. Twenty-seven obese patients were recruited into the study. The median TAFI level of the control group was 124.00; this value was significantly lower than the basal TAFI level of the obese group (p < 0.001). TAFI levels after orlistat therapy were statistically significantly lower than basal TAFI levels (p < 0.001) in the obese group. Hemostatic abnormalities including TAFI alterations represent a link between obesity and vascular thrombosis. Effective interventions should be considered in improving the obesity-associated prothrombotic risk profile.


Subject(s)
Carboxypeptidase B2/drug effects , Lactones/administration & dosage , Obesity/drug therapy , Adult , Body Weights and Measures , Carboxypeptidase B2/blood , Case-Control Studies , Female , Hemostasis , Humans , Lactones/pharmacology , Middle Aged , Orlistat , Thrombosis
15.
J Natl Med Assoc ; 98(8): 1313-7, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16916129

ABSTRACT

Obesity as a disease is a yet-unidentified sum of genetic and environmental factors. Risky eating behavior and lifestyle may bring the disease. The aim of the study was to find out risk factors for obesity factors influencing definition of obesity. Participants (n = 1500) who filled out a questionnaire about eating habits are grouped according to their body mass indices as normal weight, overweight and obese (n = 500 in each group). According to our results, the prevalence of having obese first-degree relatives is significantly higher in obese individuals (p < 0.001). Sixty-two of normal weighing subjects were university graduates, whereas this ratio was only 31% in the obese group (p < 0.001). Incidence of obesity was higher in married participants when compared to the single or divorced/widowed persons (p < 0.001). Multinomial logistic regression analysis gave the following results: risk of obesity was 57% less in participants lacking a family history of obesity when compared to the ones with a positive family history (p = 0.005). Being married increases the risk of obesity 2.5 times; being a primary school graduate increases the risk about 1.5 times. Lower educational level, unemployment and lack of counseling seem to be risk factors associated with obesity. Diverging patterns of sociodemographic features, lifestyles and perception were evident even between overweight and obese populations.


Subject(s)
Obesity/epidemiology , Adolescent , Adult , Age Factors , Aged , Educational Status , Female , Humans , Incidence , Life Style , Male , Middle Aged , Prognosis , Risk Factors , Sex Factors , Socioeconomic Factors , Turkey/epidemiology
17.
New Microbiol ; 26(3): 275-80, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12901424

ABSTRACT

Resistance emergence to carbapenem antibiotics was studied in a rat-thigh abscess model. Abscesses were developed in three groups with a total of 15 P. aeruginosa strains (three rats per strain). Groups were assigned to imipenem or meropenem treatment while one was left antibiotic-free. Test strains were fully susceptible to these antibiotics and the "Mutant Preventing Concentrations" of imipenem and meropenem over these strains were comparable. Antibiotic serum levels, assessed by serum bioassay test, were similar among therats. After four days, rats (n=45) were sacrificed and carbapenem resistant mutants were selected on imipenem (4 mg/L) and meropenem (4 mg/L) supplemented agar plates. Resistant variants of three strains, from four abscesses, were detected; one in the meropenem group, two in the imipenem and one in the untreated group. The MICs of imipenem and meropenem for the mutants were increased fourfold times or even higher of their counterparts. Resistance emergence under antibiotic pressure in P. aeruginosa has been shown in various conditions. To our knowledge, however, resistance emergence in abscess and also the comparison of imipenem and meropenem in this regard has not been studied before.


Subject(s)
Abscess/drug therapy , Carbapenems/pharmacology , Imipenem/pharmacology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Thienamycins/pharmacology , Abscess/microbiology , Animals , Drug Resistance, Bacterial , Male , Meropenem , Microbial Sensitivity Tests , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics , Rats , Rats, Wistar , Selection, Genetic
18.
Hernia ; 7(3): 130-3, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12687427

ABSTRACT

Adhesions between viscera and mesh may result in intestinal obstruction and fistulae formation. Fewer adhesions with sodium carboxymethylcellulose (SCMC)-coated polypropylene mesh (PM) has been reported, but impaired wound healing was the major concern. We investigated the adhesion-prevention effect of SCMC in different concentrations, as coating only on visceral face of PM and its effects on wound healing. A full-thickness abdominal wall defect was created in 28 rats, which were then divided into three groups. In Group I (control), the defect was repaired with PM only; in Group II and Group III, the defects were repaired with 1% and 1.6% SCMC-coated-PM, respectively. All animals were sacrificed at day 30, and histological evaluation and adhesion scoring were done. Animals in the group in which 1.6% SCMC-coated PM was used developed significantly fewer adhesions compared with other animals (P=0.04). Histological evaluation using a semiquantitative scoring system showed no difference between the groups in fibrosis and inflammation scores (P=0.9 and P=0.3, respectively), and thickness of fibrosis on mesh was also similar (P=0.5). SCMC in 1.6% concentration as coating only on the visceral face of PM reduced the incidence and severity of adhesions without impairing wound healing.


Subject(s)
Carboxymethylcellulose Sodium/pharmacology , Hernia, Ventral/surgery , Laparotomy/methods , Polypropylenes , Surgical Mesh , Tissue Adhesions/prevention & control , Animals , Coated Materials, Biocompatible , Disease Models, Animal , Female , Male , Postoperative Complications/prevention & control , Probability , Rats , Rats, Sprague-Dawley , Reference Values , Sensitivity and Specificity , Tissue Adhesions/pathology , Wound Healing/physiology
19.
J Pediatr Surg ; 36(12): 1866-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11733928

ABSTRACT

Malignant peripheral nerve sheath tumors (MPNST), also known as malignant schwannomas, are highly malignant lesions that tend to arise in the head and neck region or on the extremities, and only rarely in the retroperitoneum. These tumors are not common in children. Almost 50% of cases are associated with neurofibromatosis. When these neoplasms arise in the retroperitoneum, they usually are difficult to diagnose and to treat. Although various radiologic imaging methods are helpful for identifying some features of the mass, definitive diagnosis requires histologic examination and immunohistochemical staining. After treatment, the tumor recurs in 25% of patients. Five-year survival rates as high as 80% have been reported. Total excision, lack of invasion of surrounding tissues and vessels, and absence of neurofibromatosis, are features associated with better outcome. The authors present the case of a 1-month-old boy who had malignant schwannoma diagnosed in a unique location over the peritoneum of the anterior abdomen. The location and rapid growth of the tumor permitted early identification and total excision. J Pediatr Surg 36:1866-1868.


Subject(s)
Abdominal Muscles , Neurilemmoma/diagnosis , Retroperitoneal Neoplasms/diagnosis , Abdominal Muscles/pathology , Humans , Infant , Infant, Newborn , Male , Neurilemmoma/pathology , Neurilemmoma/surgery , Retroperitoneal Neoplasms/pathology , Retroperitoneal Neoplasms/surgery , Treatment Outcome
20.
Hernia ; 5(3): 156-7, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11759803

ABSTRACT

It is not uncommon to find the appendix vermiformis within a hernia sac; however, sliding appendiceal inguinal hernia is rare. A 9-month-old boy with an incarcerated right scrotal hernia is presented in this case report. Although the hernia was reduced through a conservative approach, appendix vermiformis remained in the hernia sac because of its attachment to the upper pole of the right testis. Exploratory surgery during the inguinal hernia repair revealed a connecting band that extended from the appendix vermiformis into the scrotum and attached to the right testicle. Histologic examination showed that the band was congenital. After reduction of an incarcerated hernia, the persistence of a thickened or a cord-like structure is a warning for the presence of a sliding hernia. We suggest that this uncommon developmental anomaly is likely to cause the processus vaginalis to remain patent, thus facilitating hernia formation.


Subject(s)
Appendix/abnormalities , Hernia, Inguinal/congenital , Testis/abnormalities , Hernia, Inguinal/surgery , Humans , Infant , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...